Atazanavir 150 MG Oral Capsule
1 INDICATIONS AND USAGE Atazanavir capsules are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in pediatric patients 6 years and older weighing at least 15 kg. Limitations of Use: Atazanavir capsules are not recommended for use in pediatric patients below the age of 3 months due to the risk of kernicterus [see Use in Specific Populations ( 8.4 )] . Use of atazanavir capsules with ritonavir in treatment-experienced patients should be guided by the number of baseline primary protease inhibitor resistance substitutions [see Microbiology ( 12.4 )] . Atazanavir capsules are a protease inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in pediatric patients 6 years and older weighing at least 15 kg. ( 1 )
teva pharmaceuticals usa, inc.
CAPSULE TURQUOISE Teva 5526
Related Pills
Atazanavir 300 MG Oral Capsule
teva pharmaceuticals usa, inc.
Atazanavir 200 MG Oral Capsule
teva pharmaceuticals usa, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Atazanavir capsules are available in the following strengths and configurations: 150 mg – capsules with light-turquoise-blue-opaque cap and aqua-blue-opaque body, imprinted “5526” on the body and “TEVA” on the cap, in bottles of 60 (NDC 0093-5526-06) with a child-resistant closure. 200 mg – capsules with light-turquoise body and light-turquoise cap, imprinted “93” over “5527” on both the cap and the body, in bottles of 60 (NDC 0093-5527-06) with a child-resistant closure. 300 mg – capsules with light-blue-opaque body and red-opaque cap, imprinted “93” over “5528” on both the cap and the body, in bottles of 30 (NDC 0093-5528-56) with a child-resistant closure. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). Store atazanavir capsules at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
More pills like CAPSULE Teva 5526